These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23566532)

  • 21. A Retrospective Study of the Cytokine Profile Changes in Mice with FVIII Inhibitor Development After Adeno-Associated Virus-Mediated Gene Therapy in a Hemophilia A Mouse Model.
    Sun J; Yuan Z; Abajas YL; Szollosi DE; Hu G; Hua B; Xiao X; Li C
    Hum Gene Ther; 2018 Mar; 29(3):381-389. PubMed ID: 28922951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved coagulation and haemostasis in haemophilia with inhibitors by combinations of superFactor Va and Factor VIIa.
    Bhat V; von Drygalski A; Gale AJ; Griffin JH; Mosnier LO
    Thromb Haemost; 2016 Mar; 115(3):551-61. PubMed ID: 26466980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correction of bleeding diathesis without liver toxicity using arenaviral-pseudotyped HIV-1-based vectors in hemophilia A mice.
    Park F
    Hum Gene Ther; 2003 Oct; 14(15):1489-94. PubMed ID: 14577928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene-based FVIIa prophylaxis modulates the spontaneous bleeding phenotype of hemophilia A rats.
    Zintner SM; Small JC; Pavani G; Dankner L; Marcos-Contreras OA; Gimotty PA; Kjelgaard-Hansen M; Wiinberg B; Margaritis P
    Blood Adv; 2019 Feb; 3(3):301-311. PubMed ID: 30705032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of bleeding for the evaluation of therapeutic preparations in small animal models of antibody-induced hemophilia and von Willebrand disease.
    Turecek PL; Gritsch H; Richter G; Auer W; Pichler L; Schwarz HP
    Thromb Haemost; 1997 Mar; 77(3):591-9. PubMed ID: 9066015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single adeno-associated virus (AAV)-murine factor VIII vector partially corrects the hemophilia A phenotype.
    Sarkar R; Xiao W; Kazazian HH
    J Thromb Haemost; 2003 Feb; 1(2):220-6. PubMed ID: 12871492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intra-articular injection of mesenchymal stem cells expressing coagulation factor ameliorates hemophilic arthropathy in factor VIII-deficient mice.
    Kashiwakura Y; Ohmori T; Mimuro J; Yasumoto A; Ishiwata A; Sakata A; Madoiwa S; Inoue M; Hasegawa M; Ozawa K; Sakata Y
    J Thromb Haemost; 2012 Sep; 10(9):1802-13. PubMed ID: 22784361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological aspects of recombinant factor VIIa (rFVIIa) in clinical use.
    Nicolaisen EM; Hansen LL; Poulsen F; Glazer S; Hedner U
    Thromb Haemost; 1996 Aug; 76(2):200-4. PubMed ID: 8865531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained FVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposon.
    Liu L; Mah C; Fletcher BS
    Mol Ther; 2006 May; 13(5):1006-15. PubMed ID: 16464640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study.
    Petersen LC; Nørby PL; Branner S; Sørensen BB; Elm T; Stennicke HR; Persson E; Bjørn SE
    Thromb Res; 2005; 116(1):75-85. PubMed ID: 15850611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of immune tolerance by neonatal intravenous injection of human factor VIII in murine hemophilia A.
    Madoiwa S; Yamauchi T; Hakamata Y; Kobayashi E; Arai M; Sugo T; Mimuro J; Sakata Y
    J Thromb Haemost; 2004 May; 2(5):754-62. PubMed ID: 15099282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk?
    Giansily-Blaizot M; Verdier R; Biron-Adréani C; Schved JF; Bertrand MA; Borg JY; Le Cam-Duchez V; Briquel ME; Chambost H; Pouymayou K; Dutrillaux F; Favier R; Martin-Toutain I; Verdy E; Gay V; Goudemand J; Navarro R; Durin A; d'Oiron R; Lambert T; Pernod G; Barrot C; Peynet J; Bastenaire B; Sie P; Stieltjes N; Torchet MF; de Moerloose P;
    Haematologica; 2004 Jun; 89(6):704-9. PubMed ID: 15194538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vivo transfection and expression of human coagulant factor VIII cDNA in mice].
    Kang WY; Wang HL; Wang H; Wang XF; Wang CZ; Fu QH; Ding QL; Wu WM; Fang Y; Wang ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr; 12(2):188-93. PubMed ID: 15157331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Generation of factor VIII gene knockout mouse by tetraploid embryo complementation technology].
    Kuang Y; Wang J; Lu X; Lu S; Zhang L; Shen C; Fei J; Wang Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):1-6. PubMed ID: 20140858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A sensitive venous bleeding model in haemophilia A mice: effects of two recombinant FVIII products (N8 and Advate(®)).
    Pastoft AE; Lykkesfeldt J; Ezban M; Tranholm M; Whinna HC; Lauritzen B
    Haemophilia; 2012 Sep; 18(5):782-8. PubMed ID: 22500820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mesenchymal stem cells derived from transgenic mice carrying human coagulation factor VIII can correct phenotype in hemophilia A mice.
    Wang Q; Gong X; Gong Z; Ren X; Ren Z; Huang S; Zeng Y
    J Genet Genomics; 2013 Dec; 40(12):617-28. PubMed ID: 24377868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circumventing furin enhances factor VIII biological activity and ameliorates bleeding phenotypes in hemophilia models.
    Siner JI; Samelson-Jones BJ; Crudele JM; French RA; Lee BJ; Zhou S; Merricks E; Raymer R; Nichols TC; Camire RM; Arruda VR
    JCI Insight; 2016 Oct; 1(16):e89371. PubMed ID: 27734034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice.
    VandenDriessche T; Vanslembrouck V; Goovaerts I; Zwinnen H; Vanderhaeghen ML; Collen D; Chuah MK
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10379-84. PubMed ID: 10468616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemophilia A ameliorated in mice by CRISPR-based in vivo genome editing of human Factor VIII.
    Chen H; Shi M; Gilam A; Zheng Q; Zhang Y; Afrikanova I; Li J; Gluzman Z; Jiang R; Kong LJ; Chen-Tsai RY
    Sci Rep; 2019 Nov; 9(1):16838. PubMed ID: 31727959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of factor VII and of activated factor VII in healthy individuals and in prothrombin complex concentrates.
    Hellstern P; Beeck H; Fellhauer A; Fischer A; Faller-Stöckl B
    Thromb Res; 1997 Jun; 86(6):493-504. PubMed ID: 9219329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.